SI1451196T1 - Uporaba substituiranih tetracikličnih imidazolnih derivatov kot antihistaminiki - Google Patents

Uporaba substituiranih tetracikličnih imidazolnih derivatov kot antihistaminiki

Info

Publication number
SI1451196T1
SI1451196T1 SI200230617T SI200230617T SI1451196T1 SI 1451196 T1 SI1451196 T1 SI 1451196T1 SI 200230617 T SI200230617 T SI 200230617T SI 200230617 T SI200230617 T SI 200230617T SI 1451196 T1 SI1451196 T1 SI 1451196T1
Authority
SI
Slovenia
Prior art keywords
brain injury
intracranial pressure
traumatic
histaminics
histamine
Prior art date
Application number
SI200230617T
Other languages
English (en)
Inventor
Frank Tegtmeier
Frans Eduard Janssens
Joseph Elisabeth Leenaerts
Rossem Koenraad Arthur Van
Manuel Jesus Jans Alcazar-Vaca
Pedro Janssen Martinez-Jimenez
Jose Manuel Bartolome-Nebreda
Antonio Janssen- Gomez-Sanchez
Francisco Javi Fernandez-Gadea
Reempts Jozef Leo Henri Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI1451196T1 publication Critical patent/SI1451196T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200230617T 2001-11-23 2002-11-22 Uporaba substituiranih tetracikličnih imidazolnih derivatov kot antihistaminiki SI1451196T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01204574 2001-11-23
EP02803410A EP1451196B1 (en) 2001-11-23 2002-11-22 The use of substituted tetracyclic imidazole derivatives as anti-histaminics
PCT/EP2002/013180 WO2003044023A1 (en) 2001-11-23 2002-11-22 The use of anti-histaminics for acute reduction of elevated intracranial pressure

Publications (1)

Publication Number Publication Date
SI1451196T1 true SI1451196T1 (sl) 2007-12-31

Family

ID=8181317

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200230813T SI1832287T1 (sl) 2001-11-23 2002-11-22 Uporaba histaminskih receptorskih antagonistov za zmanjšanje intrakranialnega tlaka
SI200230617T SI1451196T1 (sl) 2001-11-23 2002-11-22 Uporaba substituiranih tetracikličnih imidazolnih derivatov kot antihistaminiki

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200230813T SI1832287T1 (sl) 2001-11-23 2002-11-22 Uporaba histaminskih receptorskih antagonistov za zmanjšanje intrakranialnega tlaka

Country Status (26)

Country Link
US (1) US7732437B2 (sl)
EP (2) EP1451196B1 (sl)
JP (2) JP4505226B2 (sl)
KR (1) KR100967601B1 (sl)
CN (2) CN100379744C (sl)
AT (2) ATE370149T1 (sl)
AU (1) AU2002356715B2 (sl)
CA (2) CA2690483C (sl)
CY (2) CY1107472T1 (sl)
DE (2) DE60231351D1 (sl)
DK (2) DK1832287T3 (sl)
ES (2) ES2321987T3 (sl)
HK (2) HK1101672A1 (sl)
HR (1) HRP20040427B1 (sl)
HU (1) HU229118B1 (sl)
IL (4) IL162109A0 (sl)
MX (1) MXPA04004867A (sl)
NO (1) NO333656B1 (sl)
NZ (2) NZ550723A (sl)
PL (1) PL209953B1 (sl)
PT (2) PT1832287E (sl)
RU (1) RU2311418C2 (sl)
SI (2) SI1832287T1 (sl)
UA (1) UA76803C2 (sl)
WO (1) WO2003044023A1 (sl)
ZA (1) ZA200403923B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ550723A (en) 2001-11-23 2008-06-30 Janssen Pharmaceutica Nv The use of anti-histaminics for acute reduction of elevated intracranial pressure
TWI290140B (en) * 2003-08-25 2007-11-21 Schering Corp 2-Substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for thr treatment of obesity and related disorders
WO2013094021A1 (ja) * 2011-12-20 2013-06-27 トヨタ自動車株式会社 電気加熱式触媒の故障検出装置
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
ES2953520T3 (es) 2016-12-23 2023-11-14 Maregade Rx Llc Producto a baja dosis y método para el tratamiento de la diarrea
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223465B1 (hu) * 1992-12-04 2004-07-28 Janssen Pharmaceutica N.V. Allergia elleni triazolo(pirrolo, tieno vagy furán)-azepin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
TW429256B (en) 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
TW527186B (en) 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators
US6544979B1 (en) * 1997-09-18 2003-04-08 Janssen Pharmaceuticals, N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
EP1401838B1 (en) * 2001-06-12 2014-03-26 Janssen Pharmaceutica NV Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
NZ550723A (en) 2001-11-23 2008-06-30 Janssen Pharmaceutica Nv The use of anti-histaminics for acute reduction of elevated intracranial pressure

Also Published As

Publication number Publication date
KR20050044328A (ko) 2005-05-12
RU2311418C2 (ru) 2007-11-27
AU2002356715B2 (en) 2008-05-15
WO2003044023A1 (en) 2003-05-30
HUP0402357A2 (hu) 2005-02-28
ATE423599T1 (de) 2009-03-15
JP2005509680A (ja) 2005-04-14
ATE370149T1 (de) 2007-09-15
RU2004118838A (ru) 2005-04-10
MXPA04004867A (es) 2004-07-30
CN100478031C (zh) 2009-04-15
JP2009102417A (ja) 2009-05-14
IL162109A (en) 2010-04-29
CA2690483A1 (en) 2003-05-30
DE60231351D1 (de) 2009-04-09
SI1832287T1 (sl) 2009-06-30
CN100379744C (zh) 2008-04-09
ES2321987T3 (es) 2009-06-15
CY1109108T1 (el) 2014-07-02
PL369864A1 (en) 2005-05-02
CY1107472T1 (el) 2012-12-19
HK1073309A1 (en) 2005-09-30
HRP20040427A2 (en) 2005-06-30
HU229118B1 (en) 2013-08-28
PT1451196E (pt) 2007-10-25
CA2467097C (en) 2011-02-01
CA2467097A1 (en) 2003-05-30
IL162109A0 (en) 2005-11-20
NZ550723A (en) 2008-06-30
US7732437B2 (en) 2010-06-08
CN1589273A (zh) 2005-03-02
CN1895673A (zh) 2007-01-17
IL188457A (en) 2010-11-30
DE60221891T2 (de) 2008-05-08
UA76803C2 (uk) 2006-09-15
DE60221891D1 (de) 2007-09-27
HK1101672A1 (en) 2007-10-26
ES2290364T3 (es) 2008-02-16
NO20042618L (no) 2004-06-22
EP1832287B1 (en) 2009-02-25
PT1832287E (pt) 2009-05-05
NZ532718A (en) 2007-01-26
NO333656B1 (no) 2013-08-05
DK1832287T3 (da) 2009-06-08
HRP20040427B1 (en) 2012-09-30
JP4505226B2 (ja) 2010-07-21
EP1832287A2 (en) 2007-09-12
HUP0402357A3 (en) 2009-10-28
IL194992A (en) 2010-12-30
US20050070525A1 (en) 2005-03-31
IL194992A0 (en) 2009-08-03
IL188457A0 (en) 2008-03-20
KR100967601B1 (ko) 2010-07-05
DK1451196T3 (da) 2007-11-12
CA2690483C (en) 2012-07-24
EP1832287A3 (en) 2007-12-26
EP1451196B1 (en) 2007-08-15
PL209953B1 (pl) 2011-11-30
ZA200403923B (en) 2005-10-26
EP1451196A1 (en) 2004-09-01
AU2002356715A1 (en) 2003-06-10
JP4991770B2 (ja) 2012-08-01

Similar Documents

Publication Publication Date Title
IL194992A0 (en) The use of anti-histaminics for acute reduction of elevated intracranial pressure
DK2578585T3 (en) PURINONDERIVAT AS BTK kinase inhibitor
RU2004133764A (ru) Производные бензимидазола в качестве н3-гистаминовых антагонистов
WO2007131092A3 (en) Chimeric t cell receptors and related materials and methods of use
RU2007104096A (ru) Способ лечения аллергии или вызываемых аллергией поражений дыхательных путей и фармацевтическая композиция
PA8463401A1 (es) Composiciones cosmeticas con d b s y siliconas funcionalizadas
ES2676517T3 (es) Preparación cosmética ligera y resistente al agua
EP1303260A2 (en) Linkage of agents using microparticles
US20140093467A1 (en) Styling agents having maximum hold
WO2002098375A3 (en) Starch-oil composites for use in personal care applications
AR038226A1 (es) Composiciones que contienen emulsiones de aceite de silicona en agua, sales, alcoholes y solventes
US20160074292A1 (en) Mineral salts for reducing the content of cysteic acid in keratin fibres
ATE471723T1 (de) Zusammensetzung zur ophthalmischen verwendung
DE60001232T2 (de) Hautreinigungsmittel
ES2626561T3 (es) Preparación cosmética que contiene polisilicona-25 y filtros UV solubles en agua con una función ácido sulfónico
SG183211A1 (en) Gelatinous cleaning agent for contact lenses
DE602006015270D1 (de) Kosmetische Zusammensetzung enthaltend ein kationisches Tensid,einen flüssigen Fettkörper und einen Sorbitanester
ES2801855T3 (es) Octanoato de 2-propilheptilo en preparaciones cosméticas
ES2320104T3 (es) Metodo para la deformacion duradera de fibras que contienen queratina y producto correspondiente.
BR0314451A (pt) Composição lìquida de limpeza pessoal
BRPI0415296A (pt) cdna modificado para os nìveis de expressão elevados do fator viii e seus derivados
Boni Dyrk1a in cancer: good or evil? defining properties of dyrk1a kinase as a novel tumor driver
Korte et al. S 2-42: Expression of CAP1 and CAP2 in developing and adult mouse tissues
WO2002031142A3 (en) Antisense nucleic acid against alphav integrin
TH72836A (th) อนุพันธ์ของกรอัลจินิกที่ผ่านการปรับปรุงประจุบวก และองค์ประกอบของเครื่องสำอางที่มีส่วนประกอบเดียวกัน